ArticleDigital health
Photo-based deep learning for detection of pediatric adenoid hypertrophy.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This proof-of-concept study aimed to develop and preliminarily validate a hybrid artificial intelligence (AI) model that combines 2D facial photographs with clinical variables for non-invasive pediatric adenoid hypertrophy (AH) screening. Methods: 11,465 full-face photographs (2,097 children, 6-14 years) were retrospectively collected and labeled by adenoid-to-nasopharyngeal ratio (>0.6 was defined as AH). A multi-stage optimization framework was employed to develop a photo-based deep learning model (AHDNet). Subsequently, features from AHDNet were integrated with clinical variables to construct a hybrid model (HM). Comprehensive model evaluation was performed using multiple metrics and interpretability methods. AHDNet's performance was also benchmarked against 21 clinicians of varying experience. To support further model optimization, an open-access testing platform was provided. Results: For preliminary screening, AHDNet achieved an area under the receiver operating characteristic curve (AUC) of 0.669 (95% confidence interval [CI] 0.584-0.748), showing a discriminatory ability comparable to that of human raters. The HM exhibited improved performance with an AUC of 0.712 (95% CI 0.630-0.784) and more favorable calibration. Decision curve analysis (DCA) revealed that the HM maintained positive net benefit within the threshold range of 0.133 to 0.429. Interpretability analysis highlighted the eyes and mandibular angle as key discriminative regions and identified narrow maxillary dental arches and strained lip closure as significant clinical risk factors. Conclusions: As a proof-of-concept, the hybrid AI model may serve as a non-invasive tool to assist with preliminary screening for pediatric AH, potentially facilitating timely detection and reducing the risk of subsequent maxillofacial deformities associated with AH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.